Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
03/2002
03/27/2002CN1341593A Proteinase inhibitor
03/27/2002CN1341592A Proteinase inhibitor
03/27/2002CN1341590A Proteinase inhibitor
03/27/2002CN1341483A Method for preparing tetrahydrofurfuryl alcohol by furfuralcohol hydrogenation and its catalyst
03/26/2002US6362369 Phthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
03/26/2002US6362353 Manufacture of fatty acid esters of sorbitan as surfactants
03/26/2002US6362347 Method for purifying phthalides
03/26/2002US6362346 Heating mixture of furoic acid with acid catalyst
03/26/2002US6362345 Method for producing phthalic anhydride by means of catalytic vapor-phase oxidation of o-xylol/naphthalene mixtures
03/26/2002US6362343 Reacting water miscible olefin in water with acylurea imidazole compound
03/26/2002US6362231 Calcium receptor active compounds
03/26/2002US6362230 Alzheimer's disease
03/26/2002US6362223 Cardiovascular disorders
03/26/2002US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use
03/26/2002US6362190 Administering compounds such as 3-(2-phenylethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene -carboxamidomethylpyridi nyl)-2-pyrazinone, n'-((1-(aminoiminomethyl)4-piperidinyl) methyl)-n-(3,3-diphenylpropionyl)-l-proline amide
03/26/2002US6362189 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
03/26/2002US6362177 Cyclic amine derivatives and their use as drugs
03/26/2002CA2095848C Process for the preparation of pyrimidine compounds
03/26/2002CA2041588C Cyclohexenone oxime ethers, their preparation, intermediates for their preparation and their use as herbicides
03/26/2002CA2032498C Novel 8-substituted-2-aminotetralines
03/21/2002WO2002022593A1 Gaseous acid catalysis
03/21/2002WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors
03/21/2002WO2001070672A3 Compounds and methods to treat alzheimer's disease
03/21/2002WO2001034135A3 Oncolytic combinations for the treatment of cancer
03/21/2002US20020035278 Methods for synthesis of substituted tetrahydrofuran compound
03/21/2002US20020035277 Using Grignard reagent; antidepressant
03/21/2002US20020035275 Continuous process for the production of optically pure (S)- beta-hydroxy-gamma-butyrolactone
03/21/2002US20020035272 Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia
03/21/2002US20020035264 Therapy for vision disorders
03/21/2002US20020035139 COX-2 inhibitors and the prevention of the side effects of radiation therapy
03/21/2002US20020035136 Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors
03/21/2002US20020035114 Substituted dimeric compounds
03/21/2002US20020035113 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use
03/21/2002US20020035055 Cyclic acetal that forms fragrant ketone and fragrant lactone; perfumes
03/21/2002US20020034527 Antioxidants
03/20/2002EP1188812A1 Compositions of diesel fuels containing oxygenates derived from tetrahydrofurfuryl
03/20/2002EP1188753A2 Intermediates in the preparation of 3-(1-hydroxyphenyl-1-alkoximinomethyl)dioxazines
03/20/2002EP1188745A1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
03/20/2002EP1187833A1 Method of producing nitroguanidine- and nitroenamine derivatives
03/20/2002EP1187825A1 Thiophene integrin inhibitors
03/20/2002EP1187822A1 Process for the preparation of 5-carboxphthalide and its use for the production of citalopram
03/20/2002EP1187821A1 Benzofuranylsulfonates
03/20/2002EP1187805A1 Process for preparing r-(-)-carnitine from s-(-)-chlorosuccinic acid or from a derivative thereof
03/20/2002EP1187800A1 Improved process for the preparation of 3,4-dihydroxybutanoic acid and salts and lactones derived therefrom
03/20/2002EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/20/2002CN1341124A Anti-CD3 immunotoxins and therapeutic use thereof
03/20/2002CN1341112A Process for the preparation of alpha-methylene lactones
03/20/2002CN1341098A W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
03/20/2002CN1340506A Low-viscosity liquid alicyclic epoxy compound and its preparing process
03/20/2002CN1081188C Manufacture of ascorbic acid
03/20/2002CN1081185C N-arylthiohydrazone derivatives as insecticidal and acaricidal agents
03/19/2002US6359156 Controlling diseases in cereal plants
03/19/2002US6359155 Reduction of 4-halo-3-hydroxybutyric acid; cyclization
03/19/2002US6359154 Exceptional utility as antitumor agents; bioavailability and nontoxic; oral administration; e.g., 10-hydroxy-10-deacetyl baccatin iii; anticarcinogenic agents
03/19/2002US6359153 Photoresist monomers and preparation thereof
03/19/2002US6359151 Use as pesticides.
03/19/2002US6359148 For polymer, lubricants; heat, oxidation resistance, photostability
03/19/2002US6359138 4-hydroxy-piperidine derivatives
03/19/2002US6359134 Sulfonamide derivatives, their production and use
03/19/2002US6358995 Carboxylic acid derivatives having fused rings
03/19/2002US6358960 For therapy of intravascular coagulation, coronary thrombosis, cerebral infarction, cerebral embolism, transient ischemic attack, cerebrovascular disorders, pulmonary vascular diseases, deep venous thrombosis, etc.
03/19/2002US6358945 Compounds useful as anti-inflammatory agents
03/19/2002US6358887 2-Phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides
03/19/2002US6358883 Pesticidal and parasiticidal use of 1-aryl-1-(substituted thio, sulfinyl and sulfonyl)-2-nitroethane compounds
03/19/2002CA2079548C Carbamate derivatives of 4-amino-3- isoxazolidinones, 3-amino-1- hydroxypyrrolidin-2-ones and 1-amino-1- cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments
03/14/2002WO2002020505A1 Dehydrobaimuxinol derivatives use as medicaments for treating or preventing regressive diseases of brain
03/14/2002WO2002020501A2 Polyarylcarboxamides useful as lipid lowering agents
03/14/2002WO2002020500A2 Materials and methods to potentiate cancer treatment
03/14/2002WO2002020465A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
03/14/2002WO2001070673A3 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a)
03/14/2002WO2001060781A3 Diphenyl compounds, formulations and uses thereof
03/14/2002US20020032338 Enantiomerically pure compounds by reacting water and carbocycle or heterocycle having an electrophilic center in the presence of an asymmetric tetradentate ligand complexed with a metal atom, which has a geometric shape
03/14/2002US20020032230 Dihydrofuranonyl- or dihydropyrrolinonyl-phenyl compounds containing substituted thio, sulfoxide or sulfonyl groups
03/14/2002US20020032205 An alkyl amine substituted isobenzofuran compound useful for certain psychiatric and neurological disorders; potently binding to the 5-HT1A receptor
03/14/2002US20020032195 An mono or polycyclic aromatic or heteroaromatic carbamate or urea or thiacarbamoyl derivatives; inhibit production of cytokines involved in inflammatory processes
03/14/2002US20020032189 Amine compounds, their production and use
03/14/2002US20020032186 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
03/14/2002DE10042643A1 Verfahren zur Herstellung von Hydroxymethylbutyro-lacton A process for preparing Hydroxymethylbutyro-lactone
03/14/2002DE10041543A1 Novel acids and derivatives with terminal dioxo-ene structures, useful e.g. in production of polymers or pharmaceuticals, are obtained by photooxygenation ring-opening of furans, followed by reduction
03/14/2002CA2421172A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
03/13/2002EP1186594A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
03/13/2002EP1186318A2 Combination, for treating depression and anxiety, containing a 5HT1d receptor antagonist and aCNS penetrant NK-1 receptor antagonist
03/13/2002EP1185534A1 Benzopyrans annelated in c7-c8 with an aromatic heterocycle and compositions and (co)polymer matrices containing them
03/13/2002EP1185524A2 3-heteroarylalkyl substituted gaba analogs
03/13/2002EP1185509A2 INHIBITORS OF FACTOR Xa
03/13/2002EP1185508A2 Inhibitors of factor xa
03/13/2002EP1185494A2 Method of gas phase catalytic oxidation to give maleic acid anhydride
03/13/2002EP1185493A1 Quinones for treatment of diseases
03/13/2002EP1185492A1 Acid-catalysed reactions
03/13/2002EP1037884B1 Method for separating contaminants from 3-(2'-acetoxy-ethyl-dihydro-2(3h)furanone
03/13/2002CN1340095A Ferfume precursor compositions and method for expressing perfume components
03/13/2002CN1340041A 液晶化合物 Liquid crystal compound
03/13/2002CN1339436A Method for preparing xitaipulan
03/13/2002CN1339435A Method for preparing xitaipulan
03/12/2002US6355822 Process for selective reduction
03/12/2002US6355814 Process for the preparation of 3-hydroxymethyl tetrahydrofuran
03/12/2002US6355806 Regulators of cell proliferation and differentiation, agents for treating skin-related diseases
03/12/2002US6355674 Psychological disorders; antiserotonine agents
03/12/2002US6355673 Substituted diaminocarboxylic acids
03/12/2002US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents